Scarica l'app Stockscreener
0.8134
0.83%
0.0097
Precedente Chiudi:
$0.8037
Aprire:
$0.8387
Volume 24 ore:
348.94K
Relative Volume:
0.72
Capitalizzazione di mercato:
$68.70M
Reddito:
$153.73M
Utile/perdita netta:
$-106.79M
Rapporto P/E:
-0.457
EPS:
-1.78
Flusso di cassa netto:
$-115.93M
1 W Prestazione:
-6.91%
1M Prestazione:
-7.58%
6M Prestazione:
+34.53%
1 anno Prestazione:
-78.62%
Intervallo 1D:
$0.7939
$0.86
Intervallo di 1 settimana:
$0.7884
$0.8922
Portata 52W:
$0.5231
$4.60
Sutro Biopharma Inc Stock (STRO) Company Profile
Nome
Sutro Biopharma Inc
Settore
Industria
Telefono
650-392-8412
Indirizzo
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Confronta STRO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
0.8104 | 68.13M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.62 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.68 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.20 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-16 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-03-14 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-05-08 | Iniziato | BofA Securities | Buy |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-10-06 | Iniziato | Oppenheimer | Outperform |
| 2023-03-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | Ripresa | Wells Fargo | Overweight |
| 2021-06-18 | Iniziato | H.C. Wainwright | Buy |
| 2020-12-03 | Iniziato | Stifel | Buy |
| 2020-09-02 | Iniziato | Jefferies | Buy |
| 2020-07-16 | Iniziato | Wells Fargo | Overweight |
| 2020-01-13 | Iniziato | SunTrust | Buy |
| 2019-10-07 | Iniziato | BTIG Research | Buy |
| 2019-07-18 | Iniziato | Deutsche Bank | Buy |
| 2019-04-29 | Iniziato | H.C. Wainwright | Buy |
| 2018-10-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2018-10-22 | Iniziato | Piper Jaffray | Overweight |
| 2018-10-22 | Iniziato | Wedbush | Outperform |
Mostra tutto
Sutro Biopharma Inc Borsa (STRO) Ultime notizie
Sutro Biopharma Inc. recovery potential after sell offWeekly Trend Recap & Low Risk Entry Point Guides - newser.com
Does Sutro Biopharma Inc. show high probability of reboundJuly 2025 Patterns & Community Consensus Trade Alerts - newser.com
Why Sutro Biopharma Inc. stock is considered a top pickWeekly Market Summary & Reliable Breakout Stock Forecasts - newser.com
Will Sutro Biopharma Inc. stock recover after recent dropEarnings Beat & High Accuracy Buy Signal Tips - newser.com
Will earnings trigger a reversal in Sutro Biopharma Inc.2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
How Sutro Biopharma Inc. (S09) stock reacts to monetary easingJuly 2025 Review & Daily Technical Forecast Reports - newser.com
Sutro Biopharma Inc. stock trend forecastJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com
Why Sutro Biopharma Inc. stock appeals to dividend seekersJuly 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Will Sutro Biopharma Inc. stock outperform Nasdaq indexJuly 2025 Catalysts & High Accuracy Swing Trade Signals - newser.com
Can Sutro Biopharma Inc. (S09) stock deliver strong annual returnsJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
Sutro Biopharma's (STRO) "Sell (E+)" Rating Reiterated at Weiss Ratings - MarketBeat
Sutro Biopharma’s (STRO) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
What analysts say about Sutro Biopharma Inc S09 stockSector Leadership Analysis & Crush the Market with Breakout Winners - earlytimes.in
Sutro Biopharma Inc. stock outlook for YEARWeekly Gains Summary & AI Optimized Trade Strategies - newser.com
Combining machine learning predictions for Sutro Biopharma Inc.July 2025 Closing Moves & Target Return Focused Stock Picks - newser.com
Top chart patterns to watch in Sutro Biopharma Inc.Weekly Stock Recap & Real-Time Market Sentiment Alerts - newser.com
Will Sutro Biopharma Inc. stock deliver better than expected guidance2025 Risk Factors & Fast Gain Stock Tips - newser.com
How Sutro Biopharma Inc. (S09) stock reacts to fiscal policies2025 Top Gainers & High Conviction Investment Ideas - newser.com
Will a bounce in Sutro Biopharma Inc. offer an exitPortfolio Value Report & Safe Entry Trade Signal Reports - newser.com
Is Sutro Biopharma Inc. (S09) stock a momentum leaderWall Street Watch & Capital Efficient Trade Techniques - newser.com
Will Sutro Biopharma Inc. continue its uptrendMarket Risk Report & Safe Entry Momentum Stock Tips - newser.com
What analysts say about Sutro Biopharma Inc stockHigh Dividend Yield Stocks & High Yield Trading Alerts - earlytimes.in
What technical patterns form on Sutro Biopharma Inc. (S09) stock chartsWeekly Risk Summary & Proven Capital Preservation Tips - newser.com
Will Sutro Biopharma Inc. stock benefit from infrastructure spendingTrade Entry Summary & Fast Gain Stock Trading Tips - newser.com
What’s next for Sutro Biopharma Inc. stock priceJuly 2025 Trends & Momentum Based Trading Ideas - newser.com
Leading vs lagging indicators on Sutro Biopharma Inc. performanceQuarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Is Sutro Biopharma Inc. stock attractive for retirement portfoliosMarket Volume Summary & Consistent Return Investment Signals - newser.com
Bay Area biotech company, down from $1B to $78M, lays off a third of workers - SFGATE
Sutro Biopharma trims workforce again to extend cash runway | Pharmaceutical | The Pharmaletter - The Pharma Letter
Published on: 2025-10-01 07:32:19 - newser.com
Sutro Biopharma announces restructuring to extend cash runway - MSN
Sutro Biopharma Inc Azioni (STRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sutro Biopharma Inc Azioni (STRO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Leyman Barbara | Chief Business Officer |
Jul 08 '25 |
Option Exercise |
0.00 |
25,000 |
0 |
25,000 |
| Chung Jane | Chief Executive Officer |
Aug 09 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
117,058 |
| ALBINI EDWARD C | CFO AND SECRETARY |
May 15 '25 |
Option Exercise |
0.00 |
44,719 |
0 |
176,800 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
37,849 |
0 |
133,282 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
54,580 |
| Borgman Anne Elizabeth | CHIEF MEDICAL OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
69,063 |
0 |
122,161 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
Apr 11 '25 |
Option Exercise |
0.00 |
21,250 |
0 |
59,683 |
| NEWELL WILLIAM J | CEO |
Mar 05 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
299,239 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
99,027 |
| ALBINI EDWARD C | CFO AND SECRETARY |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
135,675 |
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):